E
EGZOTech
Empowering physiotherapy with robots
About EGZOTech
EGZOTech, headquartered in Gliwice, Poland, is a pioneering manufacturer of advanced rehabilitation devices. The company specializes in developing electromyography (EMG) based technologies and rehabilitation robots, such as Luna EMG and Stella BIO, to empower physical therapists and expedite patient recovery. EGZOTech serves a diverse clientele, including hospitals, clinics, and rehabilitation centers, primarily in the healthcare sector. The company operates in the global market, with over 350 robots installed in more than 20 countries by the end of 2023. EGZOTech's business model revolves around the sale and distribution of its innovative rehabilitation robots, generating revenue through direct sales, service contracts, and maintenance agreements. The company is recognized for its strong R&D capabilities and has been acknowledged as one of the fastest-growing technology firms in Central and Eastern Europe by Deloitte Technology Fast 50 CE in 2020. EGZOTech's commitment to continuous innovation and customer collaboration has earned it the trust of over 300 clients in Poland alone.
Source: Dealroom company dataAt a glance
- Founded
- 2013
- Headquarters
- Gliwice, Poland
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Satus Venture
Augere Venture
The National Centre for Research and Development
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about EGZOTech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EGZOTech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.